Birmingham, West Midlands -- (SBWIRE) -- 12/31/2013 -- Value Penny Stocks issues special report on: Fifth Street Finance Corp.(NASDAQ:FSC), Flextronics International Ltd.(NASDAQ:FLEX), VIVUS, Inc.(NASDAQ:VVUS), Oramed Pharmaceuticals, Inc.(NASDAQ:ORMP)
Fifth Street Finance Corp.(NASDAQ:FSC) opened the session at $9.21, remained amid the day range of $9.16 - $9.27, and closed the session at $9.18. The stock showed a negative performance of -0.33% in previous trading session. The stock gained a volume of 2.04 million shares and the average volume of the stock remained 2.18 million shares. Fifth Street Finance Corp. is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, and management buyouts in small and mid-sized companies.
Will FSC Get Buyers Even After The Recent Rally? Find Out Here
Flextronics International Ltd.(NASDAQ:FLEX) traded with volume of 1.96 million shares in the prior session and the average volume of the stock remained 4.86 million shares. The stock showed a positive movement of 0.65% and closed its session at $7.76. The market capitalization of the stock remained 4.79 billion. Flextronics International Ltd. provides design and manufacturing services to original equipment manufacturers (OEMs) worldwide. The company offers design and engineering services, including contract design, joint development manufacturing, and original design and manufacturing services.
Will FLEX Continue To Move Higher? Find Out Here
VIVUS, Inc.(NASDAQ:VVUS) exchanged 1.95 million shares and the average volume remained 1.65 million shares. The stock dropped -0.11% and closed the session at $9.16. The shares outstanding of the stock remained 101.70 million. VIVUS, Inc., a biopharmaceutical company, engages in developing and commercializing therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health. VIVUS, Inc. was founded in 1991 and is headquartered in Mountain View, California.
Has VVUS Found The Bottom And Ready To Gain Momentum? Find Out Here
Oramed Pharmaceuticals, Inc.(NASDAQ:ORMP) gained volume of 1.94 million shares, while the average volume remained 372,271.00 shares. The stock advanced 15.94% and finished the session Monday at $15.06. The EPS of the stock remained -0.71. Oramed Pharmaceuticals, Inc., a development stage pharmaceutical company, is engaged in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in Jerusalem, Israel.
For How Long ORMP’s Gloss will Attract Investors? Find out via this report
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)